Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist
Contact+90 (538) 677 60 18

Levodopa for Parkinson’s Disease 1957 – A Miraculous Treatment

Levodopa for Parkinson’s Disease 1957 – A Miraculous Treatment

In 1961, Austrian researchers Oleh Hornykiewicz and Walther Birkmayer published a report on L-dopa, an apparently miraculous treatment for Parkinson's disease, a central nervous system disease impairing movement control and other brain functions. The report stated:

“After L-dopa injection, bedridden patients, patients unable to sit up, patients unable to rise from a seated position and patients unable to walk when standing could perform all these activities with ease... They could even run and jump. Quiet speech... became strong and clear.”

People with Parkinson's disease (PD) experience muscle tremors, rigidity and slowed movement. PD usually involves certain brainstem  nerve cells  failing to produce enough of the  neurotransmitter  dopamine. In 1817, British apothecary James Parkinson described PD in detail in an essay on  “the shaking palsy”. In 1957, Swedish scientist Arvid Carlsson found dopamine in a brain region important for movement control. He also showed that lowering dopamine levels in animals could produce PD symptoms, which could be reversed by giving  levodopa  (a psychoactive drug also known as L-dopa).

Levodopa can cross the blood–brain barrier, enter the brain and be converted into dopamine by certain nerve cells. When levodopa is metabolised outside the brain, it can cause adverse effects such as nausea and sudden movements. Other drugs can be given to suppress this metabolism. When drug treatment is no longer effective, electrical impulses can be used as deep brain stimulation treatment.

Researchers continue to study stem-cell transplants within the brain as a possible treatment. 

Neurologist Oliver Sacks used levodopa to treat patients with encephalitis lethargica who had not moved or spoken for years.

PD is also associated with Lewy bodies  (protein deposits)  formed by abnormal accumulation of alpha-synuclein in the brain, which may lead to brain-cell death. Several genetic mutations causing Parkinson's disease are also known.

Description of the article image: A famous illustration of a patient with Parkinson's disease from British neurologist William Richard Gowers's A Manual of Diseases of the Nervous System (1886).

Historical figures mentioned in the article: James Parkinson (1755–1824), Walther Birkmayer (1910–1996), Arvid Carlsson (b. 1923), Oleh Hornykiewicz (b. 1926), Oliver Wolf Sacks (b. 1933)

Sources

Levodopa for Parkinson’s Disease 1957. Page 436.The Medical Book: From Witch Doctors to Robot Surgeons, 250 Milestones in the History of Medicine. 2012.
DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Levodopa for Parkinson’s Disease 1957 – A Miraculous Treatment

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy